Answers are grounded in this paper and cite their sources.
Autoimmune hepatitis (AIH) is a chronic immune-mediated liver disease in which persistent inflammation and relapse remain challenges despite immunosuppressive treatment. This review critically examines the roles of effector T cells (Teffs), regulatory T cells (Tregs), and monocytes/macrophages, with particular emphasis on their interactions in the hepatic inflammatory microenvironment. Teffs contribute to inflammatory responses and hepatocyte injury, whereas heterogeneous Treg alterations indicate that increased regulatory cell abundance does not necessarily ensure effective immune control. Monocytes and macrophages may modulate T-cell responses through antigen presentation, costimulation, and cytokine production, potentially reinforcing hepatic inflammation. Importantly, this review distinguishes observed changes in immune cell populations from functionally demonstrated cellular interactions and evaluates the strength of evidence supporting these mechanisms in human AIH versus experimental models. Although selected cytokine-dependent pathways have been functionally demonstrated in human AIH, the causal contributions of specific monocyte/macrophage subsets and many proposed cellular interactions remain uncertain. We propose that defining functionally relevant immune cell interactions, rather than relying solely on changes in cell abundance or activation markers, is essential for understanding persistent inflammation and relapse. Future studies integrating longitudinal immune profiling with cell-specific functional perturbation may help identify causal pathways and guide the development of more selective therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: